Millennium Management
MIRM icon

Millennium Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Millennium Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
96,213
-272,362
-74% -$27.3M ﹤0.01% 2170
2026
Q1 		$34M Buy
368,575
+124,302
+51% +$11.7M 0.01% 1123
2025
Q4 		$19.3M Sell
244,273
-64,758
-21% -$4.65M 0.01% 1614
2025
Q3 		$22.7M Buy
309,031
+20,872
+7% +$1.33M 0.01% 1542
2025
Q2 		$14.7M Sell
288,159
-191,140
-40% -$8.51M 0.01% 1882
2025
Q1 		$21.6M Sell
479,299
-47,675
-9% -$2.25M 0.01% 1433
2024
Q4 		$21.8M Buy
526,974
+71,410
+16% +$2.98M 0.01% 1457
2024
Q3 		$17.8M Buy
455,564
+190,121
+72% +$7.58M 0.01% 1648
2024
Q2 		$9.08M Sell
265,443
-274,223
-51% -$7.19M ﹤0.01% 2175
2024
Q1 		$13.6M Buy
539,666
+315,290
+141% +$8.67M 0.01% 1904
2023
Q4 		$6.62M Buy
224,376
+87,973
+64% +$2.66M ﹤0.01% 2547
2023
Q3 		$4.31M Buy
+136,403
New +$3.74M ﹤0.01% 2829
2023
Q2 		– Sell
-15,363
Closed -$369K – 6475
2023
Q1 		$369K Buy
+15,363
New +$350K ﹤0.01% 4781
2022
Q2 		– Sell
-23,115
Closed -$509K – 7285
2022
Q1 		$509K Sell
23,115
-24,746
-52% -$505K ﹤0.01% 5106
2021
Q4 		$763K Sell
47,861
-84,725
-64% -$1.32M ﹤0.01% 4665
2021
Q3 		$2.64M Buy
132,586
+87,615
+195% +$1.42M ﹤0.01% 3583
2021
Q2 		$778K Sell
44,971
-37,871
-46% -$679K ﹤0.01% 4910
2021
Q1 		$1.64M Sell
82,842
-194,033
-70% -$3.71M ﹤0.01% 3717
2020
Q4 		$4.83M Buy
276,875
+65,796
+31% +$1.29M ﹤0.01% 2477
2020
Q3 		$4.07M Buy
211,079
+200,241
+1,848% +$4.3M 0.01% 2025
2020
Q2 		$211K Sell
10,838
-84,459
-89% -$1.41M ﹤0.01% 3825
2020
Q1 		$1.33M Buy
95,297
+73,026
+328% +$1.2M ﹤0.01% 2286
2019
Q4 		$546K Sell
22,271
-103,153
-82% -$1.1M ﹤0.01% 3328
2019
Q3 		$1.26M Buy
+125,424
New +$1.54M ﹤0.01% 2717

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management's MIRM Position: Q2 2026 in Review

Millennium Management reduced its Mirum Pharmaceuticals (MIRM) stake by 74% in Q2 2026, selling an estimated $27.3M and leaving 96,213 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Millennium Management first reported a position in MIRM in Q3 2019 and has held it in 24 quarters since. The position peaked at $34M in Q1 2026. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Millennium Management held 96,213 shares of Mirum Pharmaceuticals worth $11.3M as of Q2 2026.
  • Millennium Management sold 272,362 Mirum Pharmaceuticals shares in Q2 2026, an estimated $27.3M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2170 holding.
  • Millennium Management first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 24 quarters since.
  • Millennium Management's Mirum Pharmaceuticals position peaked at $34M in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.